Education
About Us
Working with TipRanks
Follow Us
Aptose Biosciences (TSE:APS)
TSX:APS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -474.55K | $ -507.08K | $ -616.53K | $ -646.43K |
| Operating Income | $ -26.26M | $ -52.36M | $ -42.60M | $ -65.45M | $ -55.77M |
| EBITDA | $ -26.23M | $ -52.27M | $ -42.48M | $ -65.30M | $ -55.62M |
| Net Income | $ -25.43M | $ -51.21M | $ -41.82M | $ -65.35M | $ -55.24M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 6.15M | $ 9.25M | $ 46.96M | $ 79.13M | $ 122.39M |
| Total Assets | $ 10.13M | $ 12.99M | $ 51.03M | $ 82.53M | $ 126.26M |
| Total Debt | $ 10.64M | $ 1.01M | $ 1.30M | $ 574.00K | $ 1.07M |
| Net Debt | $ -5.53M | $ -8.24M | $ -35.67M | $ -38.54M | $ -116.32M |
| Total Liabilities | $ 14.67M | $ 15.89M | $ 13.29M | $ 8.29M | $ 7.35M |
| Stockholders' Equity | $ -4.54M | $ -2.90M | $ 37.74M | $ 74.24M | $ 118.92M |
| Cash Flow | |||||
| Free Cash Flow | $ -35.98M | $ -44.62M | $ -32.35M | $ -43.52M | $ -33.97M |
| Operating Cash Flow | $ -35.98M | $ -44.59M | $ -32.32M | $ -43.30M | $ -33.89M |
| Investing Cash Flow | $ 18.00K | $ 9.96M | $ 30.07M | $ -35.21M | $ 12.63M |
| Financing Cash Flow | $ 33.41M | $ 6.91M | $ 116.00K | $ 226.00K | $ 58.81M |